期刊文献+

低分子肝素在肾综合征出血热急性肾功能衰竭血液透析中的作用 被引量:1

A low molecular weight heparin for anticoagulation during hemodialysis in patients with hemorrhaglc fever with renal syndrome
下载PDF
导出
摘要 目的 比较低分子肝素(LMWH)与普通肝素(SH)在肾综合征出血热(HFRS)伴急性肾功能衰竭(ARF)患者血液透析(HD)中的疗效和安全性。方法 51例HFRS患者随机分为二组,分别进行LMWH和SH抗凝HD各79和80例次。治疗中观察患者出血情况有无加重,透析器的颜色和残血量,体外循环管道压力及有无凝血;测定活化部分凝血酶时间(APTT)与凝血酶时间(TT)并与正常值对照;测定透析两小时尿素氮、肌酐清除率(BUN、CCr)。结果 159例次血液透析均能顺利进行,无出血加重及凝血现象,LMWH组有10例次(12%),SH组有12例次(15%)静脉侧、透析管路静脉室有轻度凝血。LMWH组APTT、TT在透析2小时轻度延长,4小时后基本恢复到治疗前水平,与正常对照值相近;而SH组、APTT、TT在透析2小时、4小时均有明显延长。LMWH与SH两组间透析二小时透析器BUN、CCr无明显差异。结论 使用LMWH后APTT、TT无明显延长,引起出血危险性低,是HFRS伴ARF血液透析的理想抗凝剂。 Objective To evaluate the efficacy and safety between low molecular weight heparins(LMWH) and standard heparin(SH) in hemodialysis(HD) patients of Hemorrhagic fever with renal syndrome(HFRS).Mettiods Fifty - one HFRS patients were randomly divided into two groups.LMWH were used in 79 dialysis procedures and SH were used in 80 dialysis procedures.Bleeding complication of the patients,the visual aspect and the pressure of die extracor-poreal circuits were observed.APTT and TT,BUN and CCr on the second hour of the dialysis session were measured.Results No bleeding complications and anaplylaxis were seen in both groups,but there was alight thrombus formation occurred ten times (12%) of LMWH and twelve times (15%) of SH in the extracorporeal circuit.APTT and TT were marginally prolonged by the LMWH at 2hr and basically returned to predialysis levels at 4hr,but they were markedly prolonged by SH at 2hr and 4hr.The clearance of urea and creatinine were comparable in both groups after 2hr of the sessions.Conclusion APTT and TT were not significant prolonged by LMWH after dialysis.LMWH was effective,safe anticoagulation for die patients with HFRS.
出处 《中国血液净化》 2002年第10期28-31,共4页 Chinese Journal of Blood Purification
关键词 低分子肝素 普通肝素 肾综合征出血热 血液透析 Low molecular weight heparins Standard heparin Hemorrfiagic fever with renal syndrom Hemodialysis
  • 相关文献

参考文献7

  • 1[1]Gran E,Siguenza F, Maduell F, et al. Low molecular weight heparin (CY-216) versus unfractiionted heparin in chronic hemodialysis. Nephron,1992,62:13
  • 2[2]Holmer E, Mattsonc NS. Anticogulant and antithrombotic effect of heparin and low molecular weight heparin fragment in rabbits. Thtomb Res, 1982,25:475
  • 3[3]Schrader J, Stibble W, Armstrong VW, et al. Comparison of low molecular weight heparin to standard in hemodialysis/hemofiltration. Kidney Int,1988,33:890
  • 4[4]Goth FA, Keen ML. Precise control minimal heparinisation for high bleeding risk hemodilysis. Trans, Soc Artif Internal Organs, 1977,23:168-175
  • 5[5]Nurmohamed MT, Ten cate J, Stevens P, et al. Long-term efficacy and safety of low molecular weight heparin in chronic hemodialysis patients: a comparison with standard heparin. ASAIO Trans, 1991,37:459-461
  • 6[6]Swartz RD, Port FK. Preventing hemorrhage in high-risk hemodialysis: Regional vslowdoseheprin. Kidney Int, 1979,6:518
  • 7丁苏青,胡艳芳,裴继云.血液透析中应用抗凝剂的探讨[J].中国血液净化,2002,1(2):26-28. 被引量:7

二级参考文献5

  • 1[1]Hafnde G, Klingel R, Wandel E, et al. Laboratory control of minimal haparinizayion during hemodialysis in patients with a risk of henorrhage. Blood Coagul Fibrilysis, 1994, 5:221
  • 2[2]Hirsh T, Levine MN, Low molecular weight heparin. Blood Coagul Fibrilysis, 1992,79:1
  • 3[4]Mudaliar JH, Liem TK, Nichols WK, Lepirudin is a safe and effective anticoagulant for patients with heparin - associated antipatelet antibodies J Vase surg. 2001, Jul: 34 ( 1 ) 17 - 20
  • 4[5]Renaud H, Moriniere P. Dieval J, Low molecular weight hepar in in haemdialysis and haemofiltretion - comparison with unfractioned beparin Proc Eur Dial Transplant Assoc Eur Assoc, 1985, 21:276 -80
  • 5汪兰煜 钱莹 王玮等.低分子肝素在血液透析高危出血患者中的应用[J].中华内科杂志,2000,6(6):375-375.

共引文献6

同被引文献5

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部